Luigi Mangione Drops Planned Extreme Emotional Disturbance Defense In Thompson Murder Case
Luigi Mangione's lawyers withdrew a planned psychiatric "extreme emotional disturbance" defense in his New York state murder case over the killing of UnitedHealthcare CEO Brian Thompson on Thursday, June 18, 2026.[1]
The defense told Judge Gregory Carro in a one-line letter that it would not introduce psychiatric evidence at trial.[2] Carro issued a written order keeping psychiatric-related transcripts, emails and other documents sealed now that psychiatric evidence will not be presented.[2]
At a June 17 hearing Carro had told the court the defense intended to argue Mangione acted under "extreme emotional disturbance." Fox News Legal analyst Richard Schoenstein said asserting that theory would effectively concede Mangione killed Brian Thompson while seeking a lesser manslaughter verdict.[1]
Attorneys filed the one-sentence withdrawal a day after notifying the court they planned to pursue the psychiatric theory.[3] Analysts said the retreat lets the team avoid an imminent court deadline to turn over psychiatric materials and would make reviving the defense later much harder.[2] Mangione's next state court date is Aug. 11, 2026, and the New York state murder trial is scheduled to begin in September, with a separate federal trial expected later.[1]
The mainstream summary does not mention the legal implications of withdrawing the extreme emotional disturbance defense, which could potentially support claims of ineffective counsel against Mangione's legal team. This perspective was highlighted by social media users, who noted that the abrupt reversal might indicate that the defense team is struggling to navigate the complexities of the case. Furthermore, while the summary focuses on the procedural aspects of the defense withdrawal, it overlooks the broader context of declining public trust in the healthcare system, which may have influenced the case dynamics. A 2026 Commonwealth Fund analysis links this trust erosion to systemic issues such as lack of universal coverage and high out-of-pocket costs, factors that could resonate in a trial involving a healthcare CEO. This context suggests that the motivations behind the murder and the subsequent legal strategies could be more intertwined with societal sentiments than the summary implies.
Show source details & analysis (6 sources)
📊 Relevant Data
Under New York Penal Law § 125.25, extreme emotional disturbance is an affirmative defense to second-degree murder that, if proven by the defendant by a preponderance of the evidence, reduces the conviction to first-degree manslaughter. The defense requires proof that the defendant acted under the influence of an extreme emotional disturbance for which there was a reasonable explanation or excuse, with reasonableness determined from the viewpoint of a person in the defendant's situation under the circumstances as the defendant believed them to be.
SECTION 125.25 Murder in the second degree — New York State Senate
📌 Key Facts
- On Wednesday, June 17, 2026, Judge Gregory Carro told the court the defense intended to argue Luigi Mangione was suffering from “extreme emotional disturbance” at the time of the alleged killing.
- On Thursday, June 18, 2026, Luigi Mangione’s attorneys sent a one-line letter to Judge Carro formally withdrawing their previously filed notice that they would introduce psychiatric evidence in the New York state murder case.
- On June 18, 2026, Judge Carro issued a written order confirming that psychiatric-related transcripts, emails and documents previously handled under seal will remain sealed now that psychiatric evidence will not be presented.
- Legal analyst Richard Schoenstein told CBS that asserting an extreme emotional disturbance defense would effectively concede that Mangione killed Brian Thompson while seeking a lesser manslaughter verdict, distinguishing it from an insanity defense that seeks full acquittal.
- Richard Schoenstein also told reporters that withdrawing the psychiatric defense lets Mangione’s team avoid an imminent court deadline to turn over psychiatric materials and would make any later attempt to revive that theory far more difficult.
- At the June 17 hearing, the judge ordered the defense to promptly disclose psychiatric information because prosecutors “need to know what the malady is,” and Assistant Manhattan District Attorney Joel Seidemann complained the defense had been “stonewalling” and provided nothing about Mangione’s psychiatric state.
- Mangione’s next state court date is set for August 11, 2026, with the New York state murder trial for the killing of UnitedHealthcare CEO Brian Thompson scheduled to begin in September 2026 and a separate federal trial expected later.
📰 Source Timeline (6)
Follow how coverage of this story developed over time
- On Thursday, June 18, 2026, Mangione’s lawyers sent a one-line letter to Judge Gregory Carro stating that 'at this time' they no longer intend to introduce psychiatric evidence at trial.
- Judge Carro issued a written order on June 18, 2026, confirming that because Mangione will not present psychiatric evidence, his prior order unsealing certain psychiatric-related transcripts, emails and documents is withdrawn and those materials will remain sealed.
- The article details that at a June 17 hearing Carro had ordered the defense to promptly disclose psychiatric information to prosecutors, saying, 'They need to know what the malady is' and that he would not allow surprise on the eve of trial.
- Assistant Manhattan District Attorney Joel Seidemann complained on June 17 that the defense was 'stonewalling' and that the prosecution 'gotten nothing' regarding Mangione’s psychiatric state.
- Legal analyst Richard Schoenstein told NPR the withdrawal allows Mangione’s team to avoid the imminent court deadline to turn over psychiatric evidence and would make any later attempt to revive such a defense far more difficult.
- The NPR piece reiterates that Mangione’s state murder trial of UnitedHealthcare CEO Brian Thompson is set for early September 2026, with a separate federal trial expected later.
- CBS aired a segment on June 18, 2026, reporting that attorneys for Luigi Mangione have dropped plans for a psychiatric defense in his New York state murder case.
- CBS legal reporter Katrina Kaufman reiterated that the withdrawn psychiatric strategy related to Mangione's state trial for the killing of UnitedHealthcare CEO Brian Thompson.
- On June 18, 2026, Luigi Mangione's attorneys sent a one-sentence letter to Judge Gregory Carro formally withdrawing their previously filed notice of a psychiatric-based defense in the New York state murder case.
- Judge Carro issued a separate order on June 18, 2026, keeping prior under-seal transcripts, emails, and documents related to the now-abandoned psychiatric defense sealed despite media objections.
- Fox reports that court proceedings two weeks earlier regarding the proposed psychiatric strategy had been held under seal, prompting access challenges from media organizations.
- The article reiterates that Mangione's New York state murder trial is scheduled to begin in September 2026, with a federal trial expected to follow next year.
- On Thursday, June 18, 2026, Luigi Mangione's legal team told the New York state court they are withdrawing a psychiatric 'extreme emotional disturbance' defense in his murder trial.
- The withdrawal comes one day after the defense informed Judge Gregory Carro they would pursue the extreme emotional disturbance theory that could have reduced the murder charge to manslaughter.
- Legal analyst Richard Schoenstein told CBS that asserting an extreme emotional disturbance defense would effectively amount to admitting Mangione killed Brian Thompson but with mitigating circumstances, distinguishing it from an insanity defense that seeks full acquittal.
- Mangione's next court date in the state case is set for August 11, 2026, with the state murder trial scheduled to begin in September 2026.
- On Wednesday, June 17, 2026, Judge Gregory Carro stated in open court that Luigi Mangione's defense team will argue he was suffering from "extreme emotional disturbance" at the time of the alleged murder.
- Carro said defense counsel has formally notified the court of their intention to pursue that psychiatric theory in Mangione's upcoming New York state murder trial in the UnitedHealthcare CEO assassination/Thompson case.
- The Fox News piece characterizes Mangione in this context as the accused "UnitedHealthcare CEO assassin," tying the extreme emotional disturbance defense explicitly to that killing.